Financial Snapshot

Revenue
$327.4M
TTM
Gross Margin
81.69%
TTM
Net Earnings
-$426.5M
TTM
Current Assets
$973.7M
Q3 2024
Current Liabilities
$838.5M
Q3 2024
Current Ratio
116.13%
Q3 2024
Total Assets
$1.094B
Q3 2024
Total Liabilities
$1.191B
Q3 2024
Book Value
-$97.32M
Q3 2024
Cash
$625.5M
Q3 2024
P/E
-18.36
Nov 29, 2024 EST
Free Cash Flow
-$160.8M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue $266.7M $51.17M $7.778M $6.950M $13.38M $10.58M $1.530M $4.610M $8.120M $13.98M $20.41M $15.58M
YoY Change 421.2% 557.93% 11.91% -48.06% 26.47% 591.5% -66.81% -43.23% -41.92% -31.5% 31.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue $266.7M $51.17M $7.778M $6.950M $13.38M $10.58M $1.530M $4.610M $8.120M $13.98M $20.41M $15.58M
Cost Of Revenue $44.40M $12.14M $3.523M
Gross Profit $222.3M $39.04M $4.255M $6.953M
Gross Profit Margin 83.36% 76.28% 54.71% 100.04%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Selling, General & Admin $264.4M $221.2M $155.6M $72.56M $45.77M $25.00M $13.45M $11.47M $9.410M $6.270M $2.420M $2.690M
YoY Change 19.52% 42.19% 114.43% 58.53% 83.08% 85.87% 17.26% 21.89% 50.08% 159.09% -10.04%
% of Gross Profit 118.93% 566.71% 3656.59% 1043.58%
Research & Development $413.5M $379.6M $285.8M $248.7M $182.4M $139.5M $98.89M $65.38M $39.98M $19.20M $12.71M $11.38M
YoY Change 8.91% 32.84% 14.9% 36.35% 30.8% 41.02% 51.25% 63.53% 108.23% 51.06% 11.69%
% of Gross Profit 185.97% 972.47% 6715.98% 3577.02%
Depreciation & Amortization $18.91M $17.96M $15.39M $9.450M $6.690M $880.0K $730.0K $680.0K $560.0K $500.0K $410.0K $430.0K
YoY Change 5.31% 16.68% 62.87% 41.26% 660.23% 20.55% 7.35% 21.43% 12.0% 21.95% -4.65%
% of Gross Profit 8.51% 46.0% 361.72% 135.91%
Operating Expenses $677.9M $600.9M $456.0M $337.6M $240.1M $165.3M $113.1M $77.53M $49.94M $25.97M $15.13M $14.07M
YoY Change 12.82% 31.75% 35.1% 40.6% 45.21% 46.23% 45.84% 55.25% 92.3% 71.65% 7.53%
Operating Profit -$455.5M -$561.8M -$451.8M -$330.6M
YoY Change -18.92% 24.35% 36.65%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Interest Expense $44.07M $30.68M $67.85M -$88.55M $8.470M $24.27M -$12.83M $4.190M $8.250M $1.650M -$570.0K -$230.0K
YoY Change 43.62% -54.78% -176.62% -1145.45% -65.1% -289.17% -406.21% -49.21% 400.0% -389.47% 147.83%
% of Operating Profit
Other Income/Expense, Net $0.00 -$4.322M
YoY Change -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Pretax Income -$474.1M -$577.8M -$383.9M -$419.2M -$218.3M -$130.5M -$124.4M -$68.73M -$33.57M -$10.34M $4.710M $1.290M
YoY Change -17.94% 50.5% -8.4% 92.06% 67.25% 4.92% 80.95% 104.74% 224.66% -319.53% 265.12%
Income Tax $7.303M $5.377M -$367.0K -$220.0K -$230.0K -$390.0K -$480.0K -$230.0K -$650.0K -$680.0K $630.0K $40.00K
% Of Pretax Income 13.38% 3.1%
Net Earnings -$481.4M -$583.2M -$383.6M -$419.0M -$218.0M -$130.1M -$123.9M -$68.51M -$32.92M -$9.660M $4.080M $1.250M
YoY Change -17.45% 52.04% -8.45% 92.17% 67.58% 5.0% 80.85% 108.11% 240.79% -336.76% 226.4%
Net Earnings / Revenue -180.51% -1139.63% -4931.56% -6028.2% -1629.45% -1229.68% -8098.04% -1486.12% -405.42% -69.1% 19.99% 8.02%
Basic Earnings Per Share
Diluted Earnings Per Share -$8.55 -$10.40 -$7.003M -$8.277M -$4.688M -$3.166M -$3.684M -$2.579M -$1.385M -$421.1K $177.9K $54.49K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Cash & Short-Term Investments $399.4M $735.5M $682.1M $718.8M $592.3M $277.9M $195.4M $180.3M $119.6M $50.20M $19.40M $14.50M
YoY Change -45.69% 7.83% -5.11% 21.36% 113.13% 42.22% 8.37% 50.75% 138.25% 158.76% 33.79%
Cash & Equivalents $392.2M $444.8M $446.3M $584.5M $592.3M $277.9M $195.4M $180.3M $119.6M $50.20M $19.40M $14.50M
Short-Term Investments $7.275M $290.7M $235.8M $134.3M
Other Short-Term Assets $38.58M $31.72M $25.23M $14.00M $13.40M $12.40M $6.900M $2.000M $3.800M $600.0K $100.0K $100.0K
YoY Change 21.63% 25.71% 80.22% 4.48% 8.06% 79.71% 245.0% -47.37% 533.33% 500.0% 0.0%
Inventory $208.9M $130.7M $75.41M
Prepaid Expenses
Receivables $35.87M $11.91M $2.200M $400.0K $800.0K $0.00 $200.0K $300.0K $1.100M $1.300M $1.700M $5.700M
Other Receivables $19.90M $13.72M $20.99M $6.900M $4.600M $2.600M $2.200M $1.400M $1.100M $1.100M $0.00 $400.0K
Total Short-Term Assets $702.7M $923.5M $805.9M $740.1M $611.2M $292.9M $204.6M $184.0M $125.7M $53.20M $21.20M $20.70M
YoY Change -23.9% 14.59% 8.89% 21.09% 108.67% 43.16% 11.2% 46.38% 136.28% 150.94% 2.42%
Property, Plant & Equipment $110.6M $129.1M $126.0M $108.1M $45.10M $4.300M $2.600M $2.400M $2.400M $1.900M $2.000M $1.200M
YoY Change -14.3% 2.42% 16.6% 139.69% 948.84% 65.38% 8.33% 0.0% 26.32% -5.0% 66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.686M $30.42M $145.9M $124.5M $15.50M $17.10M
YoY Change -81.31% -79.15% 17.19% 703.23% -9.36%
Other Assets $1.500M $1.200M $300.0K $300.0K $300.0K $100.0K $0.00 $0.00
YoY Change 25.0% 300.0% 0.0% 0.0% 200.0%
Total Long-Term Assets $122.9M $166.3M $279.0M $239.7M $65.50M $26.10M $6.400M $6.100M $6.100M $5.500M $5.500M $4.700M
YoY Change -26.1% -40.41% 16.41% 265.95% 150.96% 307.81% 4.92% 0.0% 10.91% 0.0% 17.02%
Total Assets $825.6M $1.090B $1.085B $979.8M $676.7M $319.0M $211.0M $190.1M $131.8M $58.70M $26.70M $25.40M
YoY Change
Accounts Payable $94.57M $101.0M $59.42M $21.90M $27.80M $19.70M $23.80M $13.10M $8.400M $5.000M $2.500M $2.500M
YoY Change -6.4% 70.04% 171.31% -21.22% 41.12% -17.23% 81.68% 55.95% 68.0% 100.0% 0.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $25.40M $25.42M $6.995M $6.900M $5.900M $0.00 $200.0K
YoY Change -0.08% 263.42% 1.38% 16.95%
Total Short-Term Liabilities $197.3M $171.3M $100.4M $52.80M $48.00M $38.90M $23.80M $13.50M $11.40M $12.90M $20.40M $23.80M
YoY Change 15.22% 70.66% 90.07% 10.0% 23.39% 63.45% 76.3% 18.42% -11.63% -36.76% -14.29%
Long-Term Debt $618.9M $483.0M $97.97M $85.10M $30.70M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 28.14% 392.98% 15.12% 177.2%
Other Long-Term Liabilities $149.2M $172.2M $2.964M $3.200M $900.0K
YoY Change -13.31% 5708.47% -7.38% 255.56%
Total Long-Term Liabilities $768.1M $655.1M $100.9M $88.30M $31.60M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 17.25% 549.08% 14.3% 179.43%
Total Liabilities $971.3M $826.4M $201.3M $141.1M $79.60M $38.90M $23.80M $13.50M $11.40M $12.90M $20.40M $23.80M
YoY Change 17.53% 310.56% 42.65% 77.26% 104.63% 63.45% 76.3% 18.42% -11.63% -36.76% -14.29%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $7.8292 Billion

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. The firm produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The firm operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).

Industry: Pharmaceutical Preparations Peers: IO Biotech, Inc.